PREDiCT’s 3D Oncology Summit is all about showcasing the impact 3D models are having on IO and Oncology pipelines.

2018’s inaugural event saw over 80 leading scientists from 50+ different model-development and pharmaceutical organizations meet to define core criteria for the use of 3D tumor models.

This year, alongside fresh new case studies and speakers, discussions will address open questions to translatability, platform validity, alongside how additive technologies are presenting further opportunities for these models.